Wednesday, September 06, 2017 8:38:18 AM
PULM - 2.47 Pre-market now at 2.47/2.50
BZ: Pulmatrix Reports Licensing Of PUR0200 To Vectura Group; $1M Technology Access Fee Payable To Co.
Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
BZ: Pulmatrix Reports Licensing Of PUR0200 To Vectura Group; $1M Technology Access Fee Payable To Co.
Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
